Pharmacy Technician Pulse

Short-Term CGM for T1D More Effective Than Self-Monitoring Blood Glucose

Drug Topics

APRIL 24, 2024

Researchers’ objective was to assess the short-term glycemic benefits of continuous glucose monitoring (CGM) systems compared with patients with type 1 diabetes (T1D) who self-monitor.

Industry Voices—Strengthening long-term care providers' role in value-based care

Fierce Healthcare

MARCH 21, 2024

Long-term and post-acute care (LTPAC) providers play a vital role in our health system. As such, long-term and post-acute care providers are in a position to lead the way on value-based care. Continuing to improve and coordinate post-acute care can lead to higher quality and lower costs.

Racial Discrimination in Cancer Care Setting Impacts Black Patients Long-Term

Drug Topics

NOVEMBER 21, 2023

Black patients reported associating negative emotions with experiences of racial discrimination long after the experience concluded, raising concerns about long-term health outcomes.

ACOs want increased participation of long-term and post-acute care providers

Fierce Healthcare

FEBRUARY 20, 2024

Accountable care organizations are calling on the feds to increase participation of long-term and post-acute care providers in ACOs and to better incorporate episodic-based payments. Payers, providers, ACO leaders and advocacy groups convened to discuss how to improve long-term and post-acute care participation in ACOs.

A Model for Modern Pharmacy Billing and Payments in Long-Term Care Centers

Pharmacy Times

APRIL 26, 2024

Pharmacists working with long-term care centers benefit from streamlined billing to support and build patient trust.

Lean Six Sigma: Helping Long-Term Care Pharmacies Thrive in a Challenging Market

Drug Topics

FEBRUARY 14, 2024

Long-Term Care (LTC) pharmacies are playing a critical role in delivering care primarily for our aging population. Yet LTC pharmacies face many challenges, including rising costs, space constraints, labor availability and many others.

Opinion: Doctors — and patients — must seek alternatives to long-term steroids

STAT

OCTOBER 16, 2023

But while generally safe for short-term use, long-term steroids pose significant dangers. Today, many other treatments exist, but doctors often stick with the tried-and-true steroids. There are good reasons for this: They are low-cost and readily approved by insurance companies. Read the rest…

Insurance

Long-term care hospitals can't afford to treat their sickest Medicare patients, AHA says

Fierce Healthcare

JANUARY 19, 2024

Traditional Medicare’s bar for reimbursing long-term care hospitals (LTCH) for severely ill, “high-cost outlier” patients has spiked under current payment policies. |

Hospitals

Study: Pain After Heart Attack Linked With Long-Term Survival

Pharmacy Times

AUGUST 24, 2023

Notably, 65% of the participants experiencing pain at the 2-month follow up were also experiencing pain at their 12-month follow up, suggesting persistent and long-term pain.

Long-term data indicates “significant” potential of aGvHD microbiome treatment

European Pharmaceutical Review

APRIL 15, 2024

Based on the long-term survival data, at 18 months MaaT013 enabled 42 percent overall survival in all patients and 58 percent in responder patients. MaaT013 shows remarkable efficacy at 18 months, yielding more complete responses in aGvHD patients who have shown resistance to current treatments, as compared to other available therapies.

Hospitals

Examining Trends in Long-Term Opioid Use, Importance of Pharmacist-Physician Collaboration

Drug Topics

MARCH 27, 2024

At APhA 2024, 2 posters looked into how collaboration between physicians and community pharmacists is crucial when it comes to opioid prescriptions, and current opioid use patterns among older adults.

EMA pins lack of long-term data as rationale for Novartis’ failed Vijoice bid

Pharmaceutical Technology

MARCH 14, 2024

The EMA raised concerns about the lack of long-term data for Novartis Vijoice in its initial bid, as the Swiss company prepares for a new regulatory submission.

J&J reveal long-term data for novel oral peptide

European Pharmaceutical Review

MARCH 13, 2024

In the long-term extension FRONTIER 2 study , JNJ-2113 demonstrated sustained efficacy from Week 16 to Week 52, based on data presented at the American Academy of Dermatology (AAD) 2024 Annual Meeting. The post J&J reveal long-term data for novel oral peptide appeared first on European Pharmaceutical Review.

Gilead plots long-term cell therapy growth, maintains confidence in Trodelvy despite trial miss

Fierce Pharma

FEBRUARY 7, 2024

Despite markedly slower cell therapy growth from the third to the fourth quarter of 2023—and a recent setback for Trodelvy—historically HIV-focused Gilead Sciences is not discouraged amid its | Despite a tame level of fourth-quarter growth, recent advances should drive long-term cell therapy sustainability, Gilead execs said.

CVS Health rebrands healthcare services business as it plots long-term growth strategy

Fierce Healthcare

DECEMBER 4, 2023

After spending nearly $20 billion to pick up Signify Health and Oak Street Health this year, CVS rebranded its health services business to "CVS Healthspire" as it plots its long-term growth strateg | After spending nearly $20 billion to pick up Signify Health and Oak Street Health this year, CVS rebranded its health services business to "CVS (..)

ASH: AZ’s danicopan shows long-term benefit in PNH

pharmaphorum

DECEMBER 11, 2023

ASH: AZ’s danicopan shows long-term benefit in PNH Phil.Taylor Mon, 11/12/2023 - 12:08 Bookmark this

Could monkeypox infections have long-term consequences?

STAT

OCTOBER 19, 2022

Here’s another one: Because of that oversight, doctors treating people who have been infected with monkeypox can’t answer with certainty whether some of them will face any long-term health consequences, referred to as sequelae in the field of medicine. The word comes from Latin and means “that which follows.”)

Ferring reveals long-term data for cancer gene therapy

European Pharmaceutical Review

NOVEMBER 29, 2023

Following the US Food and Drug Administration (FDA)’s approval of Ferring Pharmaceuticals’ gene therapy Adstiladrin ® (nadofaragene firadenovec-vncg) in December 2022, new long-term follow up data has been revealed. The post Ferring reveals long-term data for cancer gene therapy appeared first on European Pharmaceutical Review.

FDA

Oracle CEO warns Cerner EHR business facing 'near-term' headwinds for revenue growth

Fierce Healthcare

SEPTEMBER 13, 2023

Oracle shares fell 13% Tuesday as the software giant's near-term revenue forecast was weaker than Wall Street analysts expected. " "On the business side of things, we think the Cerner business is going to get stronger and stronger," Ellison said.

Cerner

Certain Kidney Function Measures May Determine Long-Term Physical Function Decline

Pharmacy Times

OCTOBER 4, 2022

Understanding long-term frailty trajectories with kidney function measures could help prevent worse adverse health outcomes in older patients.

Finding a long-term fix to UK’s growing patient waiting list

pharmaphorum

OCTOBER 3, 2023

Finding a long-term fix to UK’s growing patient waiting list Mike.Hammerton Tue, 03/10/2023 - 09:00 Bookmark this

Evolving with the patient: Optimising CAGT post-trial long-term follow-up

pharmaphorum

OCTOBER 27, 2023

Evolving with the patient: Optimising CAGT post-trial long-term follow-up Mike.Hammerton Fri, 27/10/2023 - 08:00 Bookmark this

The Alliance for Long-Term Care Pharmacy @ Home debuts

Drug Store News

APRIL 25, 2023

The Alliance for Long-Term Care Pharmacy @ Home is a collaborative effort that aims to improve the care provided to individuals with complex medical needs living in the community.

Sanofi shares new data for long-term efficacy of Nexviazyme for Pompe disease treatment

Pharmafile

OCTOBER 6, 2023

Sanofi has shared new data for the long-term efficacy of Nexviazyme (avalglucosidease alfa) for the treatment of Pompe disease at the 28th Annual Congress of the World Muscle Society (WMS) in Charleston, South Carolina, US.

Eagle Pharmaceuticals gets grant for long-term stable bendamustine-containing composition in sterile vial

Pharmaceutical Technology

APRIL 17, 2024

Discover Eagle Pharmaceuticals Inc's patented stable bendamustine-containing composition for long-term storage. Learn about the sterile vial with antioxidants ensuring impurities less than 5% after 15 months.

Most Americans support value-based care but prefer other terms, research finds

Fierce Healthcare

AUGUST 22, 2023

Most Americans support the idea of value-based care but don’t understand or resonate with the term, according to new research from United States of Care. | In total, 64% of people in a national survey supported value-based care over the fee-for-service model.

Larotrectinib Subgroup Analyses Demonstrate Long-Term Efficacy, Safety Profile in NTRK Gene Fusion Cancer

Pharmacy Times

JUNE 2, 2023

Findings presented at the American Society of Clinical Oncology (ASCO) 2023 meeting show the long-term efficacy and safety profile of larotrectinib (Vitrakvi; Bayer) in solid tumors with NTRK gene fusion.

Durvalumab With Chemotherapy Shows Long-Term Overall Survival at 3 Years

Pharmacy Times

APRIL 18, 2024

The results were the longest survival follow-up ever reported for a phase 3 trial for biliary tract cancer.

Chemotherapy

Heart Attack Linked With Higher Risk of Other Long-Term Health Conditions

Drug Topics

FEBRUARY 19, 2024

After myocardial infarction, all-cause mortality was the most frequent event, followed by heart failure, renal failure, and atrial fibrillation.

Opinion: Adopting the term ‘preaddiction’ would be a serious mistake

STAT

MAY 25, 2023

While it’s an admirable goal, the term fails to align with the evidence. The National Institute on Drug Abuse and National Institute on Alcohol Abuse and Alcoholism recently proposed a new addition to the addiction vernacular: “ preaddiction.” The

Expert: Long-term Care Industry Needs Help of Pharmacists to Improve Infection Prevention, Control

Pharmacy Times

NOVEMBER 7, 2022

A session presenter at the ASCP 2022 Annual Meeting explained how the COVID-19 pandemic significantly magnified the importance of infection prevention and control practices in long-term care.

Long-Term Impact of C. difficile Infection (CDI) and Infection Recurrence

Pharmacy Times

SEPTEMBER 14, 2022

A gastroenterologist reviews the long-term impact of dysbiosis and Clostridioides difficile infection.

Long-Term Adverse Events from COVID-19 Infections

Drug Topics

NOVEMBER 4, 2022

Medical experts discuss potential long-term adverse effects associated with COVID-19.

Sandoz taps Evotec in long-term biosimilar development and manufacturing deal

Fierce Pharma

MAY 10, 2023

Sandoz taps Evotec in long-term biosimilar development and manufacturing deal fkansteiner Wed, 05/10/2023 - 08:39

Apellis parries Astellas' long-term Izervay data with 3-year results on its rival GA med Syfovre

Fierce Pharma

NOVEMBER 6, 2023

Now, Apellis Pharmaceuticals is putting up long-term data on Syfovre in a bid to outdo its new rival. After this summer’s FDA approval of Iveric Bio’s Izervay—the drug at the center of the $5.9 billion buyout by Japanese pharma Astellas—the battle for the geographic atrophy crown is on in the U.S.

FDA

Short-term crucial to future of AI drug discovery

pharmaphorum

MAY 30, 2023

Short-term crucial to future of AI drug discovery Mike.Hammerton Tue, 05/30/2023 - 10:53 Bookmark this

Learn the short- and long-term effects of Adderall on the body

The Checkup by Singlecare

AUGUST 29, 2023

To better understand this medication, we spoke with two experts about how Adderall works and its short-term and long-term effects on the body. Long-term effects of Adderall on the body Regularly taking Adderall is not a cure for ADHD. What is Adderall? Adderall is a brand-name drug; its generic is amphetamine-dextroamphetamine.

Controlled Substances

Controlled Substances Labelling Dosage FDA

siRNA therapy shows long-term potential in lowering LDL-C

European Pharmaceutical Review

AUGUST 28, 2023

Novartis has announced that Leqvio ® (inclisiran) , the first and only small interfering RNA (siRNA) therapy indicated to reduce low-density lipoprotein cholesterol (LDL-C), has demonstrated promising long-term results. The post siRNA therapy shows long-term potential in lowering LDL-C appeared first on European Pharmaceutical Review.

FDA

Long-Term Care Makes Positive Impact for Older Individuals

Pharmacy Times

OCTOBER 3, 2022

Ronna Hauser, PharmD, and Bri Morris, PharmD, both from the National Community Pharmacists Association, discuss long-term care facilities and how they can make an impact on that patient population.

Long-Term Care Facilities

2023 forecast: 7 immediate and long-term priorities for hospital leaders

Fierce Healthcare

DECEMBER 16, 2022

2023 forecast: 7 immediate and long-term priorities for hospital leaders. Fri, 12/16/2022 - 18:10.

Hospitals

Patients Hospitalized with COVID-19, Flu at Increased Risk of Long-Term Health Effects

Drug Topics

DECEMBER 20, 2023

Patients hospitalized for either virus had an increased risk of death, hospital readmission, and health problems in multiple organ systems over 18 months of follow-up.

Hospitals

Almirall/Lilly lebrikizumab offers potential long-term management of atopic dermatitis

pharmaphorum

SEPTEMBER 16, 2022

Atopic dermatitis (AD) is a highly prevalent chronic dermatological disease, with symptoms which include itching, dry skin, severe pain, and inflammation – all of which create considerable stress in the daily lives of patients and often negatively affect their day-to-day and long-term well-being. However, side effects do happen.

Medical Schools

Medical Schools Hospitals Dosage Labelling

Digital health companies making a long-term play for the $100B weight loss drug market

Fierce Healthcare

MAY 8, 2023

Digital health companies making a long-term play for the $100B weight loss drug market hlandi Mon, 05/08/2023 - 06:53

BioSenic and Phebra switch up terms of licensing agreement

Pharmaceutical Technology

JANUARY 16, 2024

The updated binding term sheet for an oral arsenic trioxide therapy sees Phebra take on more duties and BioSenic given royalties.

Short-Term CGM for T1D More Effective Than Self-Monitoring Blood Glucose

Industry Voices—Strengthening long-term care providers' role in value-based care

Trending Sources

Racial Discrimination in Cancer Care Setting Impacts Black Patients Long-Term

ACOs want increased participation of long-term and post-acute care providers

A Model for Modern Pharmacy Billing and Payments in Long-Term Care Centers

Lean Six Sigma: Helping Long-Term Care Pharmacies Thrive in a Challenging Market

Opinion: Doctors — and patients — must seek alternatives to long-term steroids

Long-term care hospitals can't afford to treat their sickest Medicare patients, AHA says

Study: Pain After Heart Attack Linked With Long-Term Survival

Long-term data indicates “significant” potential of aGvHD microbiome treatment

Examining Trends in Long-Term Opioid Use, Importance of Pharmacist-Physician Collaboration

EMA pins lack of long-term data as rationale for Novartis’ failed Vijoice bid

J&J reveal long-term data for novel oral peptide

Gilead plots long-term cell therapy growth, maintains confidence in Trodelvy despite trial miss

CVS Health rebrands healthcare services business as it plots long-term growth strategy

ASH: AZ’s danicopan shows long-term benefit in PNH

Could monkeypox infections have long-term consequences?

Ferring reveals long-term data for cancer gene therapy

Oracle CEO warns Cerner EHR business facing 'near-term' headwinds for revenue growth

Certain Kidney Function Measures May Determine Long-Term Physical Function Decline

Finding a long-term fix to UK’s growing patient waiting list

Evolving with the patient: Optimising CAGT post-trial long-term follow-up

The Alliance for Long-Term Care Pharmacy @ Home debuts

Sanofi shares new data for long-term efficacy of Nexviazyme for Pompe disease treatment

Eagle Pharmaceuticals gets grant for long-term stable bendamustine-containing composition in sterile vial

Most Americans support value-based care but prefer other terms, research finds

Larotrectinib Subgroup Analyses Demonstrate Long-Term Efficacy, Safety Profile in NTRK Gene Fusion Cancer

Durvalumab With Chemotherapy Shows Long-Term Overall Survival at 3 Years

Heart Attack Linked With Higher Risk of Other Long-Term Health Conditions

Opinion: Adopting the term ‘preaddiction’ would be a serious mistake

Expert: Long-term Care Industry Needs Help of Pharmacists to Improve Infection Prevention, Control

Long-Term Impact of C. difficile Infection (CDI) and Infection Recurrence

Long-Term Adverse Events from COVID-19 Infections

Sandoz taps Evotec in long-term biosimilar development and manufacturing deal

Apellis parries Astellas' long-term Izervay data with 3-year results on its rival GA med Syfovre

Short-term crucial to future of AI drug discovery

Learn the short- and long-term effects of Adderall on the body

siRNA therapy shows long-term potential in lowering LDL-C

Long-Term Care Makes Positive Impact for Older Individuals

2023 forecast: 7 immediate and long-term priorities for hospital leaders

Patients Hospitalized with COVID-19, Flu at Increased Risk of Long-Term Health Effects

Almirall/Lilly lebrikizumab offers potential long-term management of atopic dermatitis

Digital health companies making a long-term play for the $100B weight loss drug market

BioSenic and Phebra switch up terms of licensing agreement

Stay Connected